| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc. (ACAD) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ACAD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 66.1K | $1.88M | - | |
| 10% | 32.0K | $910.6K | - | |
| VP | 19.0K | $540.4K | -16,558 | |
| CEO | 14.8K | $421.1K | - | |
| Other | 13.1K | $372.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2023 | Davis Stephen68 | CEO | Sale+OE | 7,806 | $21.18 | $165,331.08 | -6.7% | +34.4% | -23.2% | |
| May 1, 2023 | Kim Austin D.66 | EVP,General Counsel, Secretary | Sale+OE | 917 | $21.18 | $19,422.06 | -3.5% | +34.4% | -23.2% | |
| Apr 10, 2023 | Kihara James62 | Principal Accounting Officer | Sale+OE | 523 | $18.14 | $9,487.22 | -9.1% | +39.2% | +2.0% | |
| Apr 6, 2023 | Teehan Brendan62 | EVP, COO, Head Of Commercial | Sale+OE | 1,751 | $18.16 | $31,798.16 | -17.1% | +31.7% | -1.9% | |
| Apr 6, 2023 | Kihara James62 | Principal Accounting Officer | Sale+OE | 701 | $18.16 | $12,730.16 | -14.2% | +31.7% | -1.9% | |
| Apr 6, 2023 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sale+OE | 1,916 | $18.16 | $34,794.56 | -20.4% | +31.7% | -1.9% | |
| Apr 6, 2023 | Davis Stephen68 | CEO | Sale+OE | 8,582 | $18.16 | $155,849.12 | -7.9% | +31.7% | -1.9% | |
| Apr 6, 2023 | Kim Austin D.66 | EVP,General Counsel, Secretary | Sale+OE | 1,456 | $18.16 | $26,440.96 | -5.9% | +31.7% | -1.9% | |
| Feb 24, 2023 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sale+OE | 577 | $18.78 | $10,836.06 | -12.3% | +29.2% | +31.0% | |
| Feb 24, 2023 | Teehan Brendan62 | EVP, COO, Head Of Commercial | Sale+OE | 461 | $18.78 | $8,657.58 | -8.2% | +29.2% | +31.0% |